1 2 3 4 5 6 7 8 9 10 11 12 13 14
далее electivity ofnatnuretic peptide family, atnal natnuretic peptide, brain natnuretic peptide and C-type netriuretic peptide Endocrinology 1992, 130 229-239 64 Grandclement В , Morel G Ultrastructural characterization of atnal natnuretic peptide receptors (ANP-R) mRNA expression in rat kidney cortex Biol Cell 1998, 90 213—222 65 Almeida P M, Suwki M, Scarborough R M et al Clearance function of type С receptors of atria natnuretic factor in rats Am J Physiol 1989, 256 R469—R475 66 Хирманов В Н Предсердный натрий-уретический гормон Тер арх 1987,59(11) 142—147 67 Itoh К, Nonoguchi H , Shiraishi N , Tomita К Gene regulation of atnal natnuretic peptide A, B, and С receptors in rat glomeruh Exp Nephrol 1999, 7 328—336 68 McDonagh Т А, Robb S D, Murdoch D R et al Biochemical detection of left-ventncular systolic dysfunction Lancet 1998, 351 9-13 69 Troughton R W, Frampton С M, Yandle Г G et al Treatment of heart failure guided by plasma aminoterminal peptide (N-BNP) concentrations Ibid 2000,355 1126—1130 70 Lerman A, Gibbons R J, Rodehefner R J et al Circulating N-terminal atnal natnuretic peptide as a marker for symptomless left-ventncular dysfunction [bid 1993, 341 1105—1109 71 Nagaya N , Nishikimi T, Goto Y et al Plasma brain natnuretic peptide is a biochemical marker for the prediction of progrew sive ventncular remodeling after cute myocardial infarction Am Heart J 1998, 135 21-28 72 Mills R M, LeJemtel T H , Horton D P et al Sustained hemodynamic effects of an infusion of nesintide (human b-type natnuretic peptide) in heart failure a randomized, doubleblind, placebo-controlled trial Natrecor Study Group J Am Coil Cardiol 1999, 34 155-162 73 Colucci W S, Elkayam U, Horton D P et al Intravenous nesintide, a natnuretic peptide, in the treatment of decompensated congestive heart failure Nesintide Study Group N Engi J Med 2000, 343 246-253 74 Aronson D, Burger A J Intravenous nesintide (human b-type natnuretic peptide) reduces plasma endothelin-1 levels in patients with decompensated heart failure Am J Cardiol 2002, 15 435-438 75 Rahman S N, Kim G E, Mathew A S et al Effects of atnal natnuretic peptide in clinical acute renal failure Kidney Int 1994,45 1731-1738 76 Algren R L, Marbury Т С, Rahman S N et al Anantide in acute tubular necrosis Aunclin Anantide Acute Renal Failure Study Group N Engi J Med 1997, 336 828-834 77 Meyer M , Pfarr E, Schnmer G et al Therapeutic use of the natnuretic peptide ulantide in acute renal failure Renal Failure 1999,21 85-100 78 Wiebe К, Meyer M, Wahlers T et al Acute renal failure following cardiac surgery is reverted by administration of Urodilatm (INN Ulantide) Eur J Med Res 1996, 1 259-265 79 Meyer M , Wiebe К, Wahlers T et al Urodilatm (INN ularitide) as a new drug for the therapy of acute renal failure following cardiac surgery Clin Exp Pharmacol Physiol 1997, 24 374-376 80 Ikram H , McClean D R, Mehta S et al Long-term beneficial hemodynamic and neurohormonal effects of vasopeptidase inhibition with omapatrilat in he далее ...